Zobrazeno 1 - 10
of 97
pro vyhledávání: '"Jordi Llinares"'
Autor:
Robbe Saesen, Matilde Machado, Bianca Crifo, Lifang Liu, Corinne de Vries, Ralf Herold, Jordi Llinares Garcia, Isabelle Huys
Publikováno v:
Frontiers in Medicine, Vol 10 (2023)
BackgroundThe European Medicines Agency (EMA) interacts with many different stakeholders involved in the development of drugs, including academic researchers. In recent years, EMA has collaborated more closely with academia, inter alia by taking part
Externí odkaz:
https://doaj.org/article/ec20d80ae9b94c39b26358493e16d82c
Autor:
Natalie M. Hendrikse, Jordi Llinares Garcia, Thorsten Vetter, Anthony J. Humphreys, Falk Ehmann
Publikováno v:
Frontiers in Medicine, Vol 9 (2022)
Biomarkers are important tools in medicines development and clinical practice. Besides their use in clinical trials, such as for enrichment of patients, monitoring safety or response to treatment, biomarkers are a cornerstone of precision medicine. T
Externí odkaz:
https://doaj.org/article/d3d43f8f51b74d96af863ee4ce55247a
Publikováno v:
Prescrire International. Jul2021, Vol. 30 Issue 228, p194-195. 2p.
Autor:
Vreman, Rick A., Heikkinen, Inkatuuli, Schuurman, Ad, Sapede, Claudine, Garcia, Jordi Llinares, Hedberg, Niklas, Athanasiou, Dimitrios, Grueger, Jens, Leufkens, Hubert G.M., Goettsch, Wim G.
Publikováno v:
In Value in Health November 2019 22(11):1275-1282
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Elisabeth Bakker, Natalie M. Hendrikse, Falk Ehmann, Daniëlla S. van der Meer, Jordi Llinares Garcia, Thorsten Vetter, Viktoriia Starokozhko, Peter G.M. Mol
Publikováno v:
Clinical Pharmacology & Therapeutics, 112(1), 69-80. Nature Publishing Group
Clinical Pharmacology and Therapeutics
Clinical Pharmacology and Therapeutics
Regulatory qualification of biomarkers facilitates their harmonized use across drug developers, enabling more personalized medicine. This study reviews various aspects of the European Medicines Agency's (EMA's) biomarker qualification procedure, incl
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Putzeist, Michelle, Heemstra, Harald E., Garcia, Jordi Llinares, Mantel-Teeuwisse, Aukje K., Gispen-De Wied, Christine C., Hoes, Arno W., Leufkens, Hubert G.M.
Publikováno v:
In Drug Discovery Today April 2012 17(7-8):352-358
Autor:
Denis Lacombe, Ad Schuurman, Jessica Imbert, Jordi Llinares Garcia, Valentina Strammiello, Ansgar Hebborn, Flora Giorgio, Edith Frénoy, Giovanni Tafuri, Niklas Hedberg, Ingvil von Mehren Sæterdal, Anne Willemsen, Chantal Belorgey, C. Favaretti, Zoe Garrett, Daniel Widmer, Anna Lefevre Skjöldebrand, Elena Petelos, François Houÿez, Marcus Guardian
Publikováno v:
International Journal of Technology Assessment in Health Care. 36:191-196
The European Network for Health Technology Assessment (EUnetHTA) organizes an annual Forum with stakeholders to receive feedback on its activities, processes, and outputs produced. The fourth edition of the EUnetHTA Forum brought together representat
Autor:
Jonathan Lind Martinsson, Peter Arlett, Rick A. Vreman, Martin Wenzl, Inneke van de Vijver, Roisin Adams, Anna Nachtnebel, Lonneke Timmers, Hans-Georg Eichler, Einar Andreassen, Suzannah Chapman, Elias Pean, Tove Ragna Reksten, Guido Rasi, Wim G. Goettsch, Marc Van de Casteele, Jordi Llinares-Garcia
Publikováno v:
International Journal of Technology Assessment in Health Care, 37(1), 1. Cambridge University Press
Performance-based managed entry agreements (PB-MEAs) might allow patient access to new medicines, but practical hurdles make competent authorities for pricing and reimbursement (CAPR) reluctant to implement PB-MEAs. We explored if the feasibility of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3b4f7d48d3f7dd1a95acfc3ddd658259
https://lirias.kuleuven.be/handle/123456789/679492
https://lirias.kuleuven.be/handle/123456789/679492